http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2304988-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e31e3a4b99c5cca32d069f8d8db34fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02736f479017c197f2c294cdcb3f2e0b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
filingDate 2005-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ba0456af32c194bdc5934d818f44e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f47b7f622f220a48ab24ab30eb7e924b
publicationDate 2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2304988-C2
titleOfInvention Method for normalizing sleep architecture of patients suffering from depression, anxiousness disorders, obsessive compulsive disorders and heavy insomnia by applying pulsating magnetic and electric stimulation during slow wave phase of human nocturnal sleep
abstract FIELD: medicine. n SUBSTANCE: method involves applying low-amplitude electric and/or magnetic stimulation without wakening patient. The stimulation treatment is carried out during slow wave phase of human nocturnal sleep at frequency belonging to 0.5-4 Hz bandwidth selected to be maximum close to patient delta-activity characteristic frequency. Continuous stimulation cycle duration is not less than 10 min repeated in all slow wave phase of sleep during night time. The total treatment course is not less than 10 nights long one after another. Positive dynamics being achieved, the treatment course is to be continued. No dynamic changes being observed, another stimulation is to be selected by changing electric stimulation for magnetic one or vice versa or for combined stimulation using electric and magnetic stimuli in turn during one night or during two following nights. n EFFECT: enhanced effectiveness of treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2801161-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2714296-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-187875-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2740249-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2677008-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10220183-B2
priorityDate 2005-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463079
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID837856
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560354
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100534514
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06296
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8CIT0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100304474
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13982
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID259252
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID542448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396099
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100037781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID852433
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397435
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID567365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403640
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PTS1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100337609
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2099
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95MI6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533490
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70678714

Total number of triples: 53.